SHARON REYNOLDS: Open Payments
NPI 1609932110 · BLAIRSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 24 payments from 12 companies in 2025. Trend: 2023 $831 · 2024 $1,001 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $95 |
| PFIZER INC. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| Edwards Lifesciences Corporation | 2 | $72 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| BridgeBio Pharma, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: CARDIOMEMS, LEQVIO, SAPIEN 3 Ultra RESILIA, VYNDAQEL, VERQUVO, NEXLETOL, LifeVest, AMVUTTRA.
Industry payments across GA — which companies pay providers there.
